Use of rhG-CSF in the collection of peripheral blood stem cells for autologous blood stem cell transplantation in acute myeloblastic leukemia

Bone Marrow Transplantation

Volumn 18, Issue 4, 1996, Pages 821-822

  Jurado, M ^a   Delgado, C ^b   Moratalla, A ^a   Casero, D ^b   Oyonarte, S ^b   De Pablos, J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b Ctro Reg de Transfus Sanguinea   (Spain)

Author keywords

Acute myeloblastic leukemia; Autologous blood stem cell transplantation; Mobilization; rhG CSF

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; AUTOTRANSPLANTATION; CASE REPORT; CLINICAL FEATURE; HUMAN; LEUKAPHERESIS; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PHENOTYPE; TRANSPLANTATION, AUTOLOGOUS; TUMOR STEM CELLS;

EID: 0029851435     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991; 77: 211-212.
2. Sheridan WP, Glenn Begley C, Juttner CA et al. Effect of peripheral-blood progenitor cells mobilised by filgastrim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-644.
3. Shimazaki C, Oku N, Ashihara E et al. Collection of peripheral blood stem cells mobilized by recombinant human granulocyte-colony stimulating factor. Bone Marrow Transplant 1992; 10: 341-346.
4. Sanz MA, De la Rubia J, Sanz JF et al. Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution. J Clin Oncol 1993; 11: 1661-1667.
5. Gale RP, Reiffers J, Juttner CA. What's new in blood progenitor cell autotransplants? Bone Marrow Transplant 1994; 14: 343-346.
6. Ohno R, Tomanoga M, Kobayashi T et al. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. New Engl J Med 1990; 323: 871-877.
7. Büchner T, Hiddemann W, Koenigsmann M et al. Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse. Blood 1991; 78: 1190-1197.
8. Koenigsmann M, Hiddemann W, Büchner T. Reversible leukaemic regrowth under GM-CSF treatment after chemotherapy for AML. Leuk Res 1991; 15: 37-41.
9. Demirer T, Buckner CD, Appelbaum FR et al. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplant 1995; 15: 915-922.
10. Mehta J, Powles R, Singhal S, Treleaven J. Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukaemia due to reinfusion of a higher number of malignant cells. Bone Marrow Transplant 1995; 15: 652-653.
11. Körbling M, Fliedner TM, Holle R et al. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival. Bone Marrow Transplant 1991; 7: 343-349.
12. Reiffers J, Körbling M, Labopin M et al. Autologous blood stem cell transplantation versus autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. Int J Cell Cloning 1992; 10: 111-113.
13. Griffin JD, Young D, Wiper HD et al. Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia. Blood 1986; 67: 1448-1453.